NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

This adverse event was reported 1398 times

These drugs are most commonly taken by patients reporting NEOVASCULAR AGE-RELATED MACULAR DEGENERATION:

# Drug Count
0 AFLIBERCEPT 274
1 RANIBIZUMAB 198
2 PENTOSAN POLYSULFATE SODIUM 141
3 BEVACIZUMAB 112
4 ASPIRIN 72
5 FARICIMAB 72
6 ASPIRIN 325 MG 71
7 ASPIRIN 81 MG 71
8 PEGCETACOPLAN 66
9 OMEPRAZOLE MAGNESIUM 65
See all common drugs associated with NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

NEOVASCULAR AGE-RELATED MACULAR DEGENERATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGCETACOPLAN 66 0.0348
1 PENTOSAN POLYSULFATE SODIUM 141 0.0203
2 BROLUCIZUMAB 62 0.0170
3 AFLIBERCEPT 274 0.0087
4 FARICIMAB 72 0.0081
5 RANIBIZUMAB 198 0.0075
6 CARBOXYMETHYLCELLULOSE SODIUM 14 0.0025
7 POVIDONE-IODINE 8 0.0019
8 ERGOCALCIFEROL 51 0.0017
9 BEVACIZUMAB-AWWB 7 0.0015
See all drugs enriched for association with NEOVASCULAR AGE-RELATED MACULAR DEGENERATION